NCT06743880

Brief Summary

  • Cervical cancer is caused by persistent infection with certain strains of the human papillomavirus (HPV), which is a very common virus transmitted through sexual activity.
  • HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time.
  • Cervical cancer is the second most common cancer among women in Egypt, after breast cancer.
  • According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women.
  • However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas. The main objectives of this KAP study are:
  • To assess the level of knowledge about HPV and HPV vaccination among the target population.
  • To investigate the attitudes and perceptions towards HPV vaccination.
  • To identify the current practices and uptake of HPV vaccination.
  • To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
323

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 20, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 20, 2024

Status Verified

December 1, 2024

Enrollment Period

Same day

First QC Date

December 17, 2024

Last Update Submit

December 17, 2024

Conditions

Keywords

Knowledge,attitude &practice

Outcome Measures

Primary Outcomes (2)

  • Knowledge about HPV

    Proportion of participants with adequate knowledge about HPV

    baseline

  • Knowledge about HPV Vaccination

    Proportion of participants with adequate knowledge about the HPV vaccine

    baseline

Study Arms (1)

health care provider group

\- Healthcare providers at the Gynecologic Oncology Unit have direct interactions with patients and can significantly influence their knowledge, attitudes, and decision-making regarding HPV vaccination.

Eligibility Criteria

Age9 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.

You may qualify if:

  • \. general population:
  • Eligibility criteria:
  • Age: 9-79 years old
  • patients and their relatives
  • Attending the Obstetrics and Gynecology, or Family Medicine clinics at Assiut University Hospital
  • Recruitment strategy:
  • Using a systematic random sampling method, every nth patient (based on the average patient load) will be approached and invited to participate in the study.
  • The target sample size for patients is a minimum of 384 participants.
  • \. Healthcare providers:
  • Eligibility criteria:
  • Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.

You may not qualify if:

  • Previous HPV Vaccination:
  • Exclude participants who have already received the complete HPV vaccination series, as their knowledge, attitudes, and practices may differ from those who are unvaccinated.
  • The study aims to understand the KAP of the unvaccinated population, which is the primary target group for intervention.
  • Severe Cognitive or Mental Impairment:
  • Exclude participants who have severe cognitive or mental impairments that may prevent them from understanding and responding to the questionnaire accurately.
  • This could include individuals with advanced dementia, severe intellectual disabilities, or acute psychiatric conditions.
  • Inability to Provide Informed Consent:
  • Exclude participants who are unable to provide informed consent due to language barriers, literacy issues, or other factors that may compromise their ability to understand the study and its implications 4- Severe Illness or Hospitalization:
  • Exclude participants who are currently hospitalized or experiencing severe illness, as their focus may be on their immediate health concerns rather than the KAP questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 Aug-Sep;45(2-3):107-14. doi: 10.1016/j.ypmed.2007.05.013. Epub 2007 Jun 2.

    PMID: 17628649BACKGROUND

MeSH Terms

Conditions

Papillomavirus InfectionsBehavior

Condition Hierarchy (Ancestors)

Sexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Abdelaaziz Mohamed Fathi, resident doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor at Assiut University hospital

Study Record Dates

First Submitted

December 17, 2024

First Posted

December 20, 2024

Study Start

January 1, 2025

Primary Completion

January 1, 2025

Study Completion

March 1, 2026

Last Updated

December 20, 2024

Record last verified: 2024-12